The Role of Native Nephrectomy in Autosomal Dominant Polycystic Kidney Disease Transplant Candidates

نویسندگان

  • Rita P. Jen
  • Zachary Klaassen
  • John M. DiBianco
  • Qiang Li
چکیده

Autosomal dominant polycystic kidney disease (ADPKD) is a genetic condition characterized by the development of multiple cysts in the kidneys, liver, and pancreas. In the United States, the mean age of presentation for ADPKD is between the 3rd and 5th decades, and approximately 50% of patients will develop ESRD by age 60, making ADPKD responsible for 7-10% of the ESRD population. The objective of this review was to assess the current literature for determining optimal timing of native nephrectomy in relation to renal transplantation for ADPKD. Regardless of timing, native nephrectomy in ADPKD patients should be avoided without clear indications due to risks, morbidity and mortality. Indications for nephrectomy may include appropriately selected patients with severe pain, recurrent infections, chronic hematuria, and symptoms of mass effect. These indications and type of graft planned can guide the ideal nephrectomy timing. Nephrectomies prior to transplantation may prevent subsequent UTIs and post-transplant infection. Simultaneous nephrectomy with kidney transplantation may be performed safely without significant graft or patient compromise in carefully selected candidates. Nephrectomy performed posttransplantation should be avoided and usually is only indicated in the emergent setting. Future studies involving larger sample sizes and with long-term graft and patient survival data are needed to further define and evaluate nephrectomies in ADPKD transplant patients.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Incidental renal cell carcinoma presenting in a renal transplant recipient with autosomal dominant polycystic kidney disease: a case report

INTRODUCTION We report an instructive case of incidental renal cell carcinoma in a patient with autosomal dominant polycystic kidney disease who underwent simultaneous bilateral native nephrectomy and living donor renal transplantation. CASE PRESENTATION A 57-year-old Asian man with end-stage kidney disease due to autosomal dominant polycystic kidney disease received a living kidney graft fro...

متن کامل

Native Nephrectomy in Renal Transplant Recipients With Autosomal-Dominant Polycystic Kidney Disease

BACKGROUND Native nephrectomy (NNx) is often done in patients with autosomal dominant polycystic kidney disease (ADPKD). Controversy exists concerning the need and timing of nephrectomy in transplant candidates. We hypothesize that post-transplant NNx does not negatively impact patient and graft survival. METHODS Among 470 ADPKD transplant recipients included in the study, 114 (24.3%) underwe...

متن کامل

KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease.

those that are being considered as potential kidney donors, need to be carefully screened and excluded from having ADPKD (KHA-CARI ADPKD Guidelines: Genetics, Imaging, and Screening subtopics), prior to living donor transplantation. Nephrectomy of a polycystic kidney prior to the time of transplantation may be required due to insufficient intra-abdominal space for the new allograft. Nephrectomy...

متن کامل

One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease.

PURPOSE Surgical management of autosomal dominant polycystic kidney disease (ADPKD) in patients awaiting renal transplantation is a challenging task. METHODS From 1998 to 2009, a total of 100 consecutive renal transplantations with simultaneous unilateral nephrectomy were performed in 59 men and 41 women with ADPKD and end-stage renal failure. About 38% received kidney allografts from living ...

متن کامل

Peritransplant management of retained native kidneys in autosomal dominant polycystic kidney disease.

As with other forms of end-stage kidney disease, transplantation is the treatment of choice for patients with autosomal dominant polycystic kidney disease (ADPKD) [1]. Transplantation is both life-extending and provides a superior quality of life for those patients who reach the need for renal replacement therapy. Most transplant centers proceed with transplantation either from a living donor o...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014